Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |